$24 million for rare and neglected diseases research

NIH announces new program to develop therapeutics for rare and neglected diseases – The National Institutes of Health is launching the first integrated, drug development pipeline to produce new treatments for rare and neglected diseases. The $24 million program jumpstarts a trans-NIH initiative called the Therapeutics for Rare and Neglected Diseases Program, or TRND.

New lead on malaria treatment

New lead on malaria treatment – Variation of natural compound cures malaria in mice. – Approximately 350 million to 500 million cases of malaria are diagnosed each year mostly in sub-Saharan Africa. While medications to prevent and treat malaria do exist, the demand for new treatments is on the rise, in part, because malaria parasites have developed a resistance to existing medications.

Genetic factors may predict depression in heart disease patients

Genetic variations contribute to depression in heart disease patients. – Individuals with heart disease are twice as likely to suffer from depression as the general population, an association the medical community has largely been unable to explain. Now, a new study by researchers at The Miriam Hospital, in conjunction with The Montr?al Heart Institute, University of Montr?al and McGill University, reveals there may be genetic variations that contribute to depression in heart disease patients.

AMP joins ACLU to challenge BRCA gene patents

AMP joins ACLU to challenge BRCA gene patents

Suit charges that Myriad Genetics BRCA1 and BRCA2 patents interfere with the free flow of information and knowledge in violation of the First Amendment and that human genes are ‘products of nature’ that cannot be patented. – The Association for Molecular Pathology (AMP) announced that it is working with the American Civil Liberties Union (ACLU) and the Public Patent Foundation to bring a lawsuit charging that patents on two human genes associated with breast and ovarian cancer are unconstitutional and should be invalidated.

Narcolepsy is an autoimmune disorder

Narcolepsy is an autoimmune disorder, Stanford researcher says. Genetic study confirms the immune system’s role in narcolepsy. – Ten years ago, Stanford University School of Medicine scientist Emmanuel Mignot, MD, PhD, and his colleagues made headlines when they identified the culprit behind the sleep disorder narcolepsy.

Autism tied to genes that influence brain cell connections

World’s largest DNA scan for autism uncovers new gene variant for disorder. Risk of autism tied to genes that influence brain cell connections. – Researchers have identified a new gene variant that is highly common in autistic children. Gene, known as CDH10, is most active in key regions that support language, speech and interpreting social behavior.

Stroke linked to genetic changes

Scientists discover genetic variant tied to increased stroke risk – First study to identify common variant influencing susceptibility in US. – Scientists have identified a previously unknown connection between two genetic variants and an increased risk of stroke, providing strong evidence for the existence of specific genes that help explain the genetic component of stroke.

New cancer gene UTX identified

Getting down to cancer basics — Cancer mutations in the heart of gene regulation. – Researchers have identified a new cancer gene – one that is common to many cancers and affects the most basic regulation of our genes.

Positive results of Albuferon in Chronic Hepatitis C

Human Genome Sciences Announces Positive Results In Second Of Two Phase 3 Trials Of Albuferon(R) In Chronic Hepatitis C – Human Genome Sciences, Inc. (Nasdaq: HGSI) announced that Albuferon (albinterferon alfa-2b) met its primary endpoint of non-inferiority to peginterferon alfa-2a (Pegasys) in ACHIEVE 1, a Phase 3 clinical trial of Albuferon in combination with ribavirin in treatment-naive patients with genotype 1 chronic hepatitis C (p=0.0008).

New monkey model for HIV

A slightly altered HIV-1 strain can infect pig-tailed macaques in the first animal model for human immunodeficiency virus infection. – By altering just one gene in HIV-1, scientists have succeeded in infecting pig-tailed macaque monkeys with a human version of the virus that has until now been impossible to study directly in animals.

Low vitamin B12 in pregnancy raises neural tube defect risk in newborn

Low levels of vitamin B12 may increase risk for neural tube defects; Vegans, vegetarians may be at risk. – Children born to women who have low blood levels of vitamin B12 shortly before and after conception may have an increased risk of a neural tube defect, according to an analysis by researchers at the National Institutes of Health, Trinity College Dublin, and the Health Research Board of Ireland.

Evolutionary biologist gets grant to study HIV

Evolutionary biologist will study HIV with grant from AIDS research foundation – Dr. Sara Sawyer will use a $120,000 grant from the Foundation for AIDS Research (amFAR) to study how the HIV virus and the cells it attacks have evolved together over time. The goal of her research is to discover new targets for drugs.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | SpiritIndia